X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (139) 139
nras mutations (137) 137
humans (123) 123
melanoma (121) 121
melanoma - genetics (83) 83
oncology (78) 78
mutation (76) 76
male (65) 65
proto-oncogene proteins b-raf - genetics (64) 64
female (63) 63
skin neoplasms - genetics (60) 60
melanoma - pathology (57) 57
middle aged (57) 57
dermatology (56) 56
cutaneous melanoma (55) 55
braf (53) 53
malignant-melanoma (49) 49
cancer (48) 48
metastatic melanoma (45) 45
aged (44) 44
genetic aspects (44) 44
skin neoplasms - pathology (44) 44
braf mutations (43) 43
adult (41) 41
gene mutations (37) 37
nras mutation (37) 37
pathology (35) 35
aged, 80 and over (32) 32
prognosis (30) 30
metastasis (29) 29
analysis (27) 27
braf mutation (27) 27
dna mutational analysis (25) 25
survival (25) 25
gtp phosphohydrolases - genetics (24) 24
membrane proteins - genetics (24) 24
neoplasms (23) 23
tumors (23) 23
uveal melanoma (23) 23
immunohistochemistry (22) 22
young adult (20) 20
care and treatment (19) 19
gene (18) 18
melanoma - metabolism (18) 18
adolescent (17) 17
nras (17) 17
open-label (17) 17
improved survival (16) 16
melanoma - diagnosis (16) 16
melanoma - mortality (16) 16
mutation - genetics (16) 16
retrospective studies (16) 16
vemurafenib (16) 16
biomarkers, tumor - genetics (15) 15
patients (15) 15
research (15) 15
skin cancer (15) 15
cell biology (14) 14
immunotherapy (14) 14
kinases (14) 14
proto-oncogene proteins c-kit - genetics (14) 14
surgery (14) 14
targeted therapy (14) 14
animals (13) 13
article (13) 13
braf v600e mutation (13) 13
kit (13) 13
melanoma - drug therapy (13) 13
development and progression (12) 12
diagnosis (12) 12
digestive system diseases (12) 12
melanocytic nevi (12) 12
neoplasm staging (12) 12
pathological features (12) 12
skin neoplasms - mortality (12) 12
activation (11) 11
child (11) 11
health aspects (11) 11
medicine, research & experimental (11) 11
skin neoplasms - diagnosis (11) 11
cell line, tumor (10) 10
copy number (10) 10
expression (10) 10
frequencies (10) 10
genetics (10) 10
medicine (10) 10
mek inhibition (10) 10
melanoma - secondary (10) 10
melanoma - therapy (10) 10
metastases (10) 10
n-ras (10) 10
nevus, pigmented - genetics (10) 10
nevus, pigmented - pathology (10) 10
pathway (10) 10
proto-oncogene proteins b-raf - metabolism (10) 10
risk factors (10) 10
signal transduction (10) 10
somatic mutations (10) 10
cells (9) 9
endocrine system diseases (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue S11, pp. 2104 - 2117
Journal Article
Cancer, ISSN 0008-543X, 04/2017, Volume 123, Issue 8, pp. 1333 - 1344
BACKGROUND Optimal treatments for vulvar and vaginal melanomas (VVMs) have not been identified. Herein, the authors compare molecular profiles between VVM and... 
genitourinary melanoma | gene profiling | vulvar melanoma | KIT proto‐oncogene receptor tyrosine kinase (KIT) mutation | mucosal melanoma | B‐Raf proto‐oncogene serine/threonine kinase (BRAF) mutation | molecular targets | vaginal melanoma | neuroblastoma rat sarcoma (NRAS) mutation | KIT proto-oncogene receptor tyrosine kinase (KIT) mutation | B-Raf proto-oncogene serine/threonine kinase (BRAF) mutation | threonine kinase (BRAF) mutation | B-Raf proto-oncogene serine | MALIGNANT-MELANOMA | DACARBAZINE | TUMORS | ONCOLOGY | KIT GENE-MUTATIONS | BRAF MUTATIONS | UNCOMMON | EXPRESSION | IPILIMUMAB | Immunohistochemistry | Melanoma - diagnosis | Humans | Middle Aged | Male | Gene Expression Profiling | Biomarkers, Tumor | Vaginal Neoplasms - genetics | Young Adult | Melanoma - genetics | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Vulvar Neoplasms - diagnosis | In Situ Hybridization, Fluorescence | Mucous Membrane - metabolism | Mucous Membrane - pathology | Vulvar Neoplasms - genetics | Proto-Oncogene Proteins B-raf - genetics | Aged | High-Throughput Nucleotide Sequencing | Mutation | Neoplasm Staging | Vaginal Neoplasms - diagnosis | Usage | Care and treatment | Gene mutations | Vulvar cancer | Genetic aspects | Research | Biological markers | Drugs | PD-1 protein | Identification methods | Estrogens | Mucosa | Clinical trials | Raf protein | Alkylation | Skin cancer | Platinum | Immunotherapy | Medical research | Threonine | Melanoma | Vagina | Exploration | Gene expression | Sensitivity | Reviews | Anthracycline | Valine | PD-L1 protein | Biomarkers | ERCC1 protein | Sampling methods | Protein-serine/threonine kinase | Progesterone | Tumors | Cancer
Journal Article
Melanoma Research, ISSN 0960-8931, 12/2018, Volume 28, Issue 6, pp. 586 - 591
Female genitourinary tract melanoma (FGTM) is a rare and often-fatal form of mucosal melanoma. We describe our institutional experience with 55 cases of FGTM,... 
female genital tract melanoma | ATRX | p53 | MEDICINE, RESEARCH & EXPERIMENTAL | VAGINAL MELANOMA | MANAGEMENT | PROGNOSTIC-FACTORS | VULVAR | PHASE-II | MALIGNANT-MELANOMA | MUCOSAL | CANCER | DERMATOLOGY | KIT MUTATION | ONCOLOGY | NRAS-MUTANT MELANOMA | Development and progression | Genetic aspects | Prognosis | Genital cancer | Melanoma | Female genital tract melanoma
Journal Article